- Home
- MBI vs AVIR Comparison
MBI vs AVIR Comparison
Compare MBI & AVIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MBI
- AVIR
- Stock Information
- Founded
- MBI 1973
- AVIR 2012
- Country
- MBI United States
- AVIR United States
- Employees
- MBI N/A
- AVIR N/A
- Industry
- MBI Property-Casualty Insurers
- AVIR Medicinal Chemicals and Botanical Products
- Sector
- MBI Finance
- AVIR Health Care
- Exchange
- MBI Nasdaq
- AVIR Nasdaq
- Market Cap
- MBI 301.1M
- AVIR 247.5M
- IPO Year
- MBI 1987
- AVIR 2020
- Fundamental
- Price
- MBI $6.05
- AVIR $3.37
- Analyst Decision
- MBI Buy
- AVIR Hold
- Analyst Count
- MBI 2
- AVIR 1
- Target Price
- MBI $6.75
- AVIR $6.88
- AVG Volume (30 Days)
- MBI 416.6K
- AVIR 528.5K
- Earning Date
- MBI 02-26-2025
- AVIR 02-26-2025
- Dividend Yield
- MBI N/A
- AVIR N/A
- EPS Growth
- MBI N/A
- AVIR N/A
- EPS
- MBI N/A
- AVIR N/A
- Revenue
- MBI N/A
- AVIR N/A
- Revenue This Year
- MBI N/A
- AVIR N/A
- Revenue Next Year
- MBI N/A
- AVIR N/A
- P/E Ratio
- MBI N/A
- AVIR N/A
- Revenue Growth
- MBI N/A
- AVIR N/A
- 52 Week Low
- MBI $3.22
- AVIR $2.75
- 52 Week High
- MBI $7.16
- AVIR $4.60
- Technical
- Relative Strength Index (RSI)
- MBI 46.25
- AVIR 55.56
- Support Level
- MBI $5.75
- AVIR $3.11
- Resistance Level
- MBI $6.47
- AVIR $3.60
- Average True Range (ATR)
- MBI 0.35
- AVIR 0.13
- MACD
- MBI -0.06
- AVIR 0.00
- Stochastic Oscillator
- MBI 22.73
- AVIR 53.17
About MBI MBIA Inc.
MBIA Inc provides financial guaranty insurance for municipal bonds and asset-backed securities in the United States and internationally. It offers an unconditional guarantee to repay the principal and interest on these securities if the issuer defaults. MBIA insures bonds sold in the primary and secondary markets, as well as those held in unit investment trusts and by mutual funds. It operates in three segments: the United States public finance insurance, corporate, and international & structured finance insurance. U.S. public finance insurance portfolio is managed through National Public Finance Guarantee Corporation. International & structured finance insurance business is managed through MBIA Insurance Corporation and its subsidiary.
About AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).